In Vitro Disease Modelling as a Tool for Identifying Neurological Drug Targets
Time: 11:00 am
day: Day One
Details:
- Exploring in vitro neurological disease modelling for identifying drug targets
- A new approach: marrying CRISPR-based functional genomics with human hiPSC-derived disease models
- Exploring success stories from modelling epilepsy and autism in hiPSC-derived neurons using CRISPR/Cas9 genome editing
